CMAJ • January 3, 2006; 174 (1). doi:10.1503/cmaj.1050178.
© 2006 CMA Media Inc. or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, S.
Related Collections
Right arrow Clostridium difficile

Letters

Biopeptides and immune exclusion

Sujoy Khan

Department of Immunopathology, St Bartholomew's Hospital, West Smithfield, London, UK

Successful probiotics have the ability to adhere to the gut preventing attachment of pathogenic bacteria and help to restore immunologic quiescence. Unfortunately, Nandini Dendukuri and colleagues' systematic review1 was unable to find clinical benefit for treatment of Clostridium difficile–associated diarrhea (CDAD).

The important question is, Can probiotics or biologically active peptides induce a lasting immune response? Probiotics stimulate the synthesis and secretion of polymeric IgA, the antibody that protects mucosal surfaces against harmful bacterial invasion, the concept underlying immune exclusion. Appropriate colonization with probiotics can thus help to produce a balanced T helper (Th) cell response. An imbalance in Th cells partly contributes to clinical disease: Th2 imbalance contributes to atopic disease and Th1 imbalance contributes to Crohn's disease and Helicobacter pylori-induced gastritis.

LeBlanc and colleagues2 demonstrated that oral administration of an immunologically active peptide (derived after extensive proteolysis by Lactobacillus helveticus) enhanced immunomodulatory action and increased IgA+ B-lymphocytes in the intestinal lamina propria of mice, and offered protection against further Escherichia coli 0157:H7 challenge. Benyacoub and colleagues3 showed that the probiotic organism Enterococcus faecium SF68 offered specific humoral and cellular (increased CD4+ in Peyer's patches and spleen) responses against Giardia intestinalis infection in mice.

Perhaps we are just beginning to understand the complex coexistence and interdependence between microbes and man.

Footnotes

Competing interests: None declared.


REFERENCES

  1. Dendukuri N, Costa V, McGregor M, et al. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ 2005;173(2):167-70.[Abstract/Free Full Text]
  2. LeBlanc J, Fliss I, Matar C. Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk. Clin Diagn Lab Immunol 2004; 11(6):1171-81.[Abstract/Free Full Text]
  3. Benyacoub J, Perez PF, Rochat F, et al. Enterococcus faecium SF68 enhances the immune response to Giardia intestinalis in mice. J Nutr2005; 135 (5): 1171-6.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, S.
Related Collections
Right arrow Clostridium difficile